Table 1 Inclusion criteria for the four groups used in the present study
From: Influence of APOE genotype in primary age-related tauopathy
Study group | Characteristics for inclusion |
|---|---|
Normal pathology for age | Braak stage 0 |
Thal phase 0–1 | |
No other significant pathological changes | |
AD pathological changes | Braak stage III or higher |
Thal phase 3 or higher | |
No other significant pathological changes | |
Possible PART | Braak stage III or lower |
Thal phase 1–2 | |
No other disease associated with NFTs present | |
Definite PART | Braak stage III or lower |
Thal phase 0 | |
No other disease associated with NFTs present |